Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Ar, Belch"'
Autor:
Margaret Macro, Andrew Ar Belch, Antoine Tinel, Nathalie Meuleman, Jean Yves Mary, Christian Rose, Paula Rodriguez-Otero, Philippe Moreau, Wenming Chen, Michel Attal, Marie Lorraine Chretien, William Renwick, Kihyun Kim, Meletios A. Dimopoulos, Eileen M Boyle, Xavier Leleu, Michael Sturniolo, Thierry Facon, Heinz Ludwig, Mara Silvia Monzini, Vanessa Houck, Elena Zamagni, Adrian Tempescul, Salomon Manier, Cyrille Hulin, Shien Guo, Mohamad Mohty, Bruno M. Costa
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2019, ⟨10.1038/s41375-019-0539-0⟩
Leukemia, 2019, ⟨10.1038/s41375-019-0539-0⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2019, ⟨10.1038/s41375-019-0539-0⟩
Leukemia, 2019, ⟨10.1038/s41375-019-0539-0⟩
Patients with multiple myeloma are generally older and vary in fitness levels, which may influence the clinical benefit of treatment. Patients from the large, phase 3 FIRST trial in newly diagnosed multiple myeloma (NDMM) were retrospectively investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a562b6d51f21d0a472d0997eba185f4f
https://pubmed.ncbi.nlm.nih.gov/31980732
https://pubmed.ncbi.nlm.nih.gov/31980732
Publikováno v:
Leukemia. 12:505-509
The malignant clone in myeloma is not eradicated by chemotherapy. Cyclosporins inhibit drug transport mechanisms, particularly the multidrug transporter p-glycoprotein 170, leading to their use as chemosensitizers. In myeloma, clonotypic blood B cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58139eba7e50ea6bc6a4e5703028e536
https://doi.org/10.1038/sj.leu.2400984
https://doi.org/10.1038/sj.leu.2400984
Publikováno v:
Blood. 77:1796-1803
Recently, several malignant cell types have been reported to express colony-stimulating factor-1 (CSF-1) transcripts; however, the clinical significance of CSF-1 in malignancy has not been investigated. Using a CSF-1 radioimmunoassay, we surveyed con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e70333aafbf0138cf94242f7028f82b
https://doi.org/10.1182/blood.v77.8.1796.bloodjournal7781796
https://doi.org/10.1182/blood.v77.8.1796.bloodjournal7781796
Autor:
Ju, Mingyan1 (AUTHOR), Deng, Tingting2 (AUTHOR), Jia, Xuemin3 (AUTHOR), Gong, Menglin1 (AUTHOR), Li, Yuying1 (AUTHOR), Liu, Fanjie4 (AUTHOR) liufj198211@126.com, Yin, Ying5 (AUTHOR) 563298098@qq.com
Publikováno v:
Diabetology & Metabolic Syndrome. 6/26/2024, Vol. 16, p1-10. 10p.
Publikováno v:
Europe PubMed Central
In multiple myeloma (MM), the VDJ rearrangement of the immunoglobulin heavy chain expressed by MM plasma cells provides a unique clonotypic marker. Although clonotypic MM cells have been found in the circulation, their number has been controversial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ccc99d1ed9c91b4b45b62ff24bae5475
http://europepmc.org/abstract/med/9763569
http://europepmc.org/abstract/med/9763569
Publikováno v:
Europe PubMed Central
DNA aneuploidy characterizes a proportion of malignant bone marrow (BM)-localized plasma cells in multiple myeloma (MM). This analysis shows that for most MM patients, circulating clonotypic B cells in MM are also hyperdiploid. Although all normal B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b92f4740eb99320fcbf87a8b377b9aab
http://europepmc.org/abstract/med/10690543
http://europepmc.org/abstract/med/10690543
Autor:
Sp, Treon, Ja, Mollick, Urashima M, Teoh G, Chauhan D, Atsushi Ogata, Raje N, Jh, Hilgers, Nadler L, Ar, Belch, Lm, Pilarski, Kc, Anderson
Publikováno v:
Europe PubMed Central
Monoclonal antibodies (MoAbs) that selectively identify Muc-1 core protein (MoAbs DF3-P, VU-4H5) determinants were used to identify the Muc-1 glycoform present on 7 multiple myeloma (MM) cell lines, 5 MM patient plasma cells, 12 MM patient B cells, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::af9144dca6b314dfe7f62fed68ffed98
http://europepmc.org/abstract/med/9949172
http://europepmc.org/abstract/med/9949172
Publikováno v:
Europe PubMed Central
Peripheral blood mononuclear cells (PBMC) from patients with multiple myeloma (MM) are here shown to include 23% +/- 2% of CD34+ cells, the majority of which coexpress CD19, as identified by a panel of 17 anti-CD34 antibodies. The expression of CD34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3127420632ab4aba5593aaca745895a0
http://europepmc.org/abstract/med/9057669
http://europepmc.org/abstract/med/9057669
Publikováno v:
Europe PubMed Central
Although chemotherapy effectively reduces the plasma cell burden in multiple myeloma (MM), the disease recurs. MM includes circulating and bone marrow (BM) localized components. A large majority of circulating CD11b+ MM B cells (81%) express an IgH V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fca8f0e99b90ff4b89881d3a6028dc85
http://europepmc.org/abstract/med/9345062
http://europepmc.org/abstract/med/9345062
Autor:
Setyawan, Annaas Budi1 abs564@umkt.ac.id, Satria, Andri Praja1, Arung, Enos Tangke2, Paramita, Swandari3
Publikováno v:
Systematic Reviews in Pharmacy. 2023, Vol. 14 Issue 2, p91-93. 3p.